Jeevandeep Mishra: Thrombotic Complications and Risk in COVID-19
Jeevandeep Mishra, Assistant Professor at Indore Institute of Pharmacy, Pithampur Road, Opp. IIM, Rau, Indore, shared a post on LinkedIn about a recent article he co-authored with Nimita Manocha, adding:
”I am proud to share a significant milestone in my academic journey-my book chapter titled ‘Thrombotic Events and Comprehensive Risk of SARS-CoV-2: An Overview’ has been published with Bentham Science.
This work provides a detailed overview of thrombotic complications associated with COVID-19, highlighting the underlying pathophysiological mechanisms, including hyperinflammatory responses, platelet activation, and the coagulation cascade.
It also explores the increased risk of conditions such as venous thromboembolism (VTE), pulmonary embolism (PE), deep vein thrombosis (DVT), and arterial thrombosis in affected patients.
Being part of this research has been an enriching experience, allowing me to deepen my understanding of the clinical and molecular aspects of COVID-19 and its complications.
This publication reinforces my commitment to advancing knowledge in pharmacology and healthcare research. I look forward to contributing further to impactful scientific work that addresses real-world health challenges.
I would like to extend my heartfelt gratitude to Dr. Nimita Grover Manocha ma’am (Principal, IIP) for her constant support, guidance, and encouragement throughout this journey. ”
Title: Thrombotic Events and Comprehensive Risk of SARS-CoV-2: An Overview
Authors: Nimita Manocha, Jeevandeep Mishra
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery